Skip to Main Content

Paper Details

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.
Oncogene
17
2020
13C, HIF1, LDHA, MCT1, MCT4, MYCN, MYCN oncogene, MYCN-regulated metabolic gene, Monocarboxylate, Monocarboxylate Transporter 1, NAD+, NADH, SLC16A, SLC16A1, SR13800, cancer, glucose, glutamine, glutathione, high, high-, high-risk neuroblastoma, hypoxia-inducible factor, lactate, luciferase, luciferase reporter, monocarboxylate, monocarboxylate transporter 1, neuroblastoma, neuroblastoma cell, neuroblastoma cells, neuroblastoma tumors, neuroblastomas, nicotinamide adenine dinucleotide, oxygen, pyruvate, tricarboxylic acid, vincristine, xenograft tumors
Author NameAffiliation
David A ScottSanford-Burnham Prebys Medical Discovery Institute
Andrei L OstermanSanford-Burnham Prebys Medical Discovery Institute
Michelle HaberChildren's Cancer Institute, Lowy Cancer Research Centre
Jamie I FletcherChildren's Cancer Institute, Lowy Cancer Research Centre
Jamie I Fletcher
  • 1 - 5

Datasets

Release 1.2